New patent for Boehringer Ingelheim drug JARDIANCE

August 24, 2021 Comments Off Posted in: Patent Added

Annual Drug Patent Expirations for JARDIANCE Jardiance is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from four suppliers. There are six patents…

The post New patent for Boehringer Ingelheim drug JARDIANCE appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.